J.C. Ruffinelli

Epigenetic prediction of response to anti-PD-1 treatment in non-small-cell lung cancer: a multicentre, retrospective analysis

M. Duruisseaux, Anna Martínez‐Cardús, María Eréndira Calleja-Cervantes et al. · The Lancet Respiratory Medicine · 2018 · 214 citations · Full text

Anti-pd-1 Treatment, Medicine, Retrospective Analysis +10

ANCHOR CRC: Results From a Single-Arm, Phase II Study of Encorafenib Plus Binimetinib and Cetuximab in Previously Untreated <i>BRAF</i>^V600E-Mutant Metastatic Colorectal Cancer

Eric Van Cutsem, Rona Yaeger, Takayuki Yoshino et al. · Journal of Clinical Oncology · 2023 · 86 citations · Full text

Predicting immunotherapy outcomes under therapy in patients with advanced NSCLC using dNLR and its early dynamics

Laura Mezquita, Isabel R. Preeshagul, Édouard Auclin et al. · European Journal of Cancer · 2021 · 56 citations · Full text

Advanced Nsclc, Early Dynamics, Disease Progression +9

Geriatric assessment may help decision-making in elderly patients with inoperable, locally advanced non-small-cell lung cancer

Maite Antonio, Juana Saldaña, Jenniffer Linares et al. · British Journal of Cancer · 2018 · 45 citations · Full text

The PALBONET Trial: A Phase II Study of Palbociclib in Metastatic Grade 1 and 2 Pancreatic Neuroendocrine Tumors (GETNE-1407)

Enrique Grande, Àlex Teulé, Teresa Alonso‐Gordoa et al. · The Oncologist · 2020 · 40 citations · Full text